Good morning,
Welcome to the first issue of The Everhealth Weekly — a Monday briefing that takes the newest, most rigorous science in prevention and makes it usable, whether you’re managing your own health or the health of your patients. This week points in one direction: medicine is moving from population averages to your biology. A weight-loss drug is showing unexpected cancer signals, your genes and your sleep are turning out to be inseparable, and cardiology just redrew the map on cholesterol.
— The Everhealth Institute team
This Week in the Evidence
GLP-1 drugs linked to slower cancer spread
Among patients with obesity-related cancers, those taking GLP-1 receptor agonists (the Ozempic/Wegovy class) progressed to stage IV disease less often than matched patients on an older diabetes drug — for example, 10% vs 20% in breast cancer and 10% vs 22% in non-small-cell lung cancer. Tumors expressing more GLP-1 receptor also tracked with lower mortality.
Source: The ASCO Post (May 2026)
Your sleep and your genes are writing the same story on your brain
Researchers looked at variants of AQP4 — a gene governing the brain’s overnight “waste-clearance” (glymphatic) system — alongside people’s sleep. Carriers of certain variants lost grey matter faster when they slept less, and the same variant could look protective or harmful depending entirely on sleep habits. The gene didn’t act alone; it acted through behavior.
Cholesterol care resets — and moves prevention earlier
The new lipid guideline restores firm LDL targets (under 70 mg/dL for high-risk adults), elevates the coronary calcium (CAC) scan to a top-tier tool — a score of zero can justify safely holding off on a statin — and, for the first time, recommends measuring lipoprotein(a) once in every adult’s lifetime to catch inherited risk a standard panel misses.
The Long View
The Long View
The end of the average patient
For a century, medicine has run on averages. A drug “works” if it beats placebo across thousands of people; a diet is “healthy” if the population does better on it. That machinery gave us statins and seat belts — but it has a blind spot the size of a person, because you are not the average of a trial.
This week’s science keeps circling that blind spot. A fiber intervention that failed on average quietly helped the people whose gut bacteria could ferment it. A sleep habit that ages one person’s brain protects another’s, depending on a single gene. A weight-loss drug turns out to carry signals no one was looking for. In each case, the interesting story isn’t the average — it’s who responds, and why.
This is the frontier prevention is moving toward: reading the individual signal in genomics, biomarkers, and biometrics, and matching the intervention to the person rather than the population. It’s less glamorous than it sounds. It means measuring more, assuming less, and being willing to say “the average says X, but your biology says Y.” It means treating a normal-looking lab as a question, not a conclusion.
The tools to do this — inexpensive genetic markers, continuous biometrics, richer biomarker panels — are arriving faster than the habit of using them. The clinicians and patients who close that gap first will spend the next decade preventing disease that everyone else only diagnoses. That’s the whole project: not the average patient, but the actual one.
Do This Week
- 1Protect your sleep like it’s medicine — because for your brain, it is. Aim for a consistent 7–9 hours. The overnight window is when your brain clears metabolic waste; short-changing it appears to matter most for those genetically predisposed to cognitive decline.
- 2Ask for one number you’ve probably never had: Lp(a). It’s a one-time blood test that reveals inherited cardiovascular risk a standard cholesterol panel can miss. The new guideline says every adult should have it once.
- 3Treat “normal” results as a starting point, not a finish line. If something in your health feels off despite reassuring labs, that’s a reason to look closer — often the individual signal hides underneath the population-normal range.
- 4Feed the gut that feeds you. Fiber’s benefit depends on the bacteria fermenting it, so variety wins — beans, oats, berries, nuts, and vegetables across the week beat any single supplement.